Deep Dive: Novo Nordisk & Eli Lilly Stumble Into Next Phase of Ozempic Era
Two pharma giants, Eli Lilly and Novo Nordisk, are in a high-stakes race for leadership in the $150 billion GLP-1 obesity drug market. We examine Lilly’s latest earnings, the mixed results from its oral pill orforglipron, and Novo’s push with higher-dose oral semaglutide. We also look at how manufacturing scale, global expansion, and a growing compounding drug controversy could shape the outcome. This is the inside story of the GLP-1 wars and the companies vying to define the future of weight loss.This video is for informational purposes only and reflects the views of the host and guest, not Public Holdings or its subsidiaries. Mentions of assets are not recommendations. Investing involves risk, including loss. Past performance does not guarantee future results. For full disclosures, visit Public.com/disclosures.
--------
11:03
--------
11:03
Tesla Abandons Dojo Program, Sweetgreen Tanks as Sales Plunge
Stock market update for August 8, 2025. This video is for informational purposes only and reflects the views of the host and guest, not Public Holdings or its subsidiaries. Mentions of assets are not recommendations. Investing involves risk, including loss. Past performance does not guarantee future results. For full disclosures, visit Public.com/disclosures.
--------
9:59
--------
9:59
Apple Charms Trump with Extra $100B U.S. Investment, Eli Lilly's New Obesity Pill Underwhelms
Stock market update for August 7, 2025. This video is for informational purposes only and reflects the views of the host and guest, not Public Holdings or its subsidiaries. Mentions of assets are not recommendations. Investing involves risk, including loss. Past performance does not guarantee future results. For full disclosures, visit Public.com/disclosures.
--------
9:28
--------
9:28
Uber Boosts Guidance on Bookings Strength, Disney Streaming & Parks Fuels Earnings Beat
Stock market update for August 6, 2025.This video is for informational purposes only and reflects the views of the host and guest, not Public Holdings or its subsidiaries. Mentions of assets are not recommendations. Investing involves risk, including loss. Past performance does not guarantee future results. For full disclosures, visit Public.com/disclosures.
--------
9:58
--------
9:58
Palantir's Revenue Hits $1B for First Time, TSMC Investigates Theft of Chip Trade Secrets
Stock market update for August 5, 2025. WATCH: Palantir deep diveThis video is for informational purposes only and reflects the views of the host and guest, not Public Holdings or its subsidiaries. Mentions of assets are not recommendations. Investing involves risk, including loss. Past performance does not guarantee future results. For full disclosures, visit Public.com/disclosures.
Daily stock market update in under 10 minutes. Stay up to date with the companies making the biggest moves and learn about the economic news that can help you be a better investor. Hosted by Zaid Admani. Created by Public.com.
UK